Kardium Announces Successful Results From GLOBAL-AF Study
News | EP Mapping and Imaging Systems | October 15, 2019

October 15, 2019 — Kardium Inc. announced that the Globe...

FDA Issues Final Guidances on Guidewires, Intravascular Catheters and Delivery Systems
News | Guidewires | October 11, 2019

October 11, 2019 — The U.S. Food and Drug Administration (FDA) issued two final guidances for the performance...

Medtronic Initiates Worldwide Pivotal Study of Extravascular Implantable Cardioverter Defibrillator
News | Implantable Cardioverter Defibrillator (ICD) | October 11, 2019

October 11, 2019 — Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational...

An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no statistically significant mortality increase. This was one of the first major reviews of trial data for patients who were treated with a paclitaxel coated device used in peripheral vessels following a meta analysis study of paclitaxel device trials published in December 2018 that showed a mortality safety signal. This was a major discussion during the FDA townhall meeting at the #TCT2019.
News | Drug-Eluting Balloons | October 10, 2019

October 10, 2019 — An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no...

BackBeat CNT is the flagship therapy of Orchestra BioMed Inc. It is a bioelectronic treatment that immediately, substantially and chronically lowers blood pressure (BP) while simultaneously modulating the autonomic nervous system (ANS).

The BackBeat CNT system is a bioelectronic treatment that immediately, substantially and chronically lowers blood pressure (BP) while simultaneously modulating the autonomic nervous system (ANS). 

News | Hypertension | October 10, 2019

October 10. 2019 — Late-breaking results from its MODERATO II double-blind, randomized study of BackBeat Cardiac...

TCT 2019 Late-breaking Presentations in the main arena. The top interventional cardiology studies of 2019. #TCT #TCT19 #TCT2019
Feature | TCT | October 11, 2019

October 10, 2019 — Here are the Cardiovascular Research Foundation (CRF) 12 late-breaking trials and 16 late-...

Fujifilm Upgrades Next-Generation Synapse Cardiology PACS
News | Cardiac PACS | October 10, 2019

October 9, 2019 – Fujifilm Medical Systems U.S.A. Inc. recently launched Synapse...

Canon Medical Launches Alphenix Encore Plus Program
News | Angiography | October 09, 2019

October 9, 2019 — In the complex and fast-paced world of healthcare, customers face the challenge of staying up-to-...

Acutus Medical and Innovative Health Collaborate to Increase Patient Access to Electrophysiology Care
News | EP Mapping and Imaging Systems | October 09, 2019

October 9, 2019 — Acutus Medical and Innovative Health announced a partnership that will offer advanced...

FDA Clears Abbott's High Sensitivity Troponin-I Blood Test
Technology | Blood Testing | October 09, 2019

October 9, 2019 — Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has...

FDA Grants Breakthrough Device Designation for Valiant Thoracoabdominal Aortic Aneurysm Stent Graft
News | Stent Grafts | October 09, 2019

October 9, 2019 — Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and...

Overlay Init